Comment by dahinds

This isn't really the issue, most of the cost of reviewing new drug applications is covered by user fees. And most of the cost and time required for getting a drug approved is in the clinical trials. FDA resources aren't really the bottleneck, the FDA is generally faster than its counterparts in other countries.